SCHEMBL61859

SCHEMBL61859

C#CC#C[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2105710 0.68
SCHEMBL142043 0.68
SCHEMBL5985489 0.64
SCHEMBL12163216 0.64
SCHEMBL8770031 0.64
SCHEMBL13617410 0.64
SCHEMBL12163217 0.64
SCHEMBL2030 0.61
SCHEMBL27667508 0.57
SCHEMBL412482 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 726 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024143067-A1 PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, COLOR FILTER, IMAGE DISPLAY APPARATUS, AND CURED PRODUCT FORMING METHOD 三菱ケミカル株式会社 2024-07-04 WO disclosed
CN-118284670-A Colored resin composition, colored resin composition set, and color filter 三菱化学株式会社 2024-07-02 CN disclosed
WO-2024121129-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024119278-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024122565-A1 PHOTOSENSITIVE COLORED RESIN COMPOSITION, CURED PRODUCT, PARTITION WALL, ORGANIC ELECTROLUMINESCENT ELEMENT, COLOR FILTER, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2024-06-13 WO disclosed
US-20240176164-A1 OPTICAL ELEMENT, EYEGLASS LENS, AUTONOMIC NERVE REGULATION METHOD, AND EVALUATION METHOD FOR OPTICAL ELEMENT MITSUI CHEMICALS, INC. (JP) 2024-05-30 US disclosed
EP-3986873-B9 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2024-05-29 EP disclosed
CN-118076922-A Colored resin composition, color filter and image display device 三菱化学株式会社 2024-05-24 CN disclosed
US-20240158343-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-05-16 US disclosed
WO-1993010120-A1 MARCFORTINE/PARAHERQUAMIDE DERIVATIVES USEFUL AS ANTIPARASITIC AGENTS THE UPJOHN COMPANY (US) 1993-05-27 WO disclosed
WO-1993008191-A1 AZABICYCLO OXIME AND AMINE CHOLINERGIC AGENTS AND METHODS OF TREATMENT WARNER-LAMBERT COMPANY (US) 1993-04-29 WO disclosed
CN-1069729-A Dihydropyridazinone, pyridazinone and related compound thereof as sterilant ROHM & HAAS (US) 1993-03-10 CN disclosed
WO-1993002090-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1993-02-04 WO disclosed
EP-0524161-A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO COMPANY (US) 1993-01-20 EP disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 US disclosed
EP-0478195-A1 Dihydropyridazinones, pyridazinones and related compounds as fungicides ROHM AND HAAS COMPANY (US) 1992-04-01 EP disclosed
EP-0445731-A1 Azabicyclo and azacyclo oxime and amine cholinergic agents and pharmaceutically acceptable salts thereof WARNER-LAMBERT COMPANY (US) 1991-09-11 EP disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
CN-1045261-A Guanidine derivatives, their production and pesticides TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1990-09-12 CN disclosed